BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 27, 2009
View Archived Issues
Phase II trials of JNJ-42160443 in various types of pain are under way
Read More
Potent in vitro antiviral activity of enterovirus capsid inhibitor V-073 supports future development
Read More
Roche presents results from third quarter of 2009
Read More
Recombinant adenovirus serotype 26 HIV-1 vaccine safe, immunogenic in humans
Read More
Canakinumab trials show efficacy in juvenile idiopathic arthritis and gouty arthritis
Read More
Pharming reports results from preclinical study of rhC1INH in ischemic brain injury
Read More
Phase I trial of recombinant human acid sphingomyelinase in type B Niemann-Pick disease reported
Read More
In vivo evaluation of the novel nAChR agonist PF-4888086 in models of antipsychotic activity
Read More
EMEA grants positive opinion for The Medicines Company's Angiox in PCI
Read More
MedImmune reports interim data from ongoing trials of LAIV 2009 H1N1 vaccine
Read More
Bone formation/resorption biomarkers predict response to Re-186 HEDP therapy in prostate cancer
Read More
Eisai and TSD Japan enter into agreement for denileukin diftitox in Japan
Read More
SuperGen and GSK to collaborate on novel epigenetic therapeutics
Read More
CXCR3 antagonists claimed by sanofi-aventis for rheumatoid arthritis
Read More
Janssen discloses MC-5 receptor ligands for treatment of dermatological conditions
Read More
Ohio State University developing AR ablating agents for treating prostate cancer
Read More
Cephalon to acquire BioAssets Development Corporation
Read More
Astellas terminates development of antihuman osteopontin antibody ASK-8007 in RA
Read More
Ablynx wins award for successfully progressing antithrombotic ALX-0081 to phase II
Read More
PTC Therapeutics initiates phase II clinical trial of ataluren in hemophilia
Read More
FDA committee to review Gilead's aztreonam for P. aeruginosa infection in CF
Read More
FDA grants emergency use authorization to BioCryst's peramivir for 2009 H1N1 influenza
Read More
Psynova Neurotech and RBM identify diagnostic biomarkers for schizophrenia
Read More
FDA grants marketing clearance to Axis-Shield's anti-CCP assay in RA
Read More
Prometheus Laboratories launches ProOncDx diagnostic cancer tests in U.S.
Read More
